Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Acerand Therapeutics (Shanghai) Limited
This study is a Phase I/II, open-label, multicentre study of ACE-86225106 administered orally in patients with advanced solid tumors.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted